Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Mass spectrometry quantification of clusterin in the human brain

Published

Author(s)

Junjun J. Chen, Meiyao M. Wang, Illarion V. Turko

Abstract

A multifunctional glycoprotein clusterin has been associated with late-onset Alzheimer’s disease (AD). This finding should prompt further investigation to define the role of clusterin in AD phenotypes. For that reason, the development of techniques to quantify level, potential post-translational modifications, and isoforms of clusterin would be important. We have developed a quantitative technique based on multiple reaction monitoring mass spectrometry to measure clusterin in the human postmortem brain tissues.
Citation
Molecular Neurodegeneration
Volume
7

Keywords

multiple reaction monitoring, mass spectrometry, isotope-labeled standard, quantification, Alzheimer's disease

Citation

Chen, J. , Wang, M. and Turko, I. (2012), Mass spectrometry quantification of clusterin in the human brain, Molecular Neurodegeneration, [online], https://doi.org/10.1186/1750-1326-7-41 (Accessed May 28, 2024)

Issues

If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.

Created August 20, 2012, Updated November 10, 2018